Heriot-Watt University Featured PhD Programmes
University of Kent Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Sheffield Featured PhD Programmes
Monash University Featured PhD Programmes
"leukemia"×
10 miles

leukemia PhD Projects, Programs & Scholarships

We have 9 leukemia PhD Projects, Programs & Scholarships

  • "leukemia" ×
  • clear all
Order by 
Showing 1 to 9 of 9
  Hematopoietic Stem Cell Genetics: Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  Prof Claus Nerlov, Dr P Vyas
Application Deadline: 26 July 2019
Using single cell biology and genetics to understand how hematopoietic stem cells normally sustain blood formation, and how this process is altered during ageing and when leukemia develops.
  Targeting TPT1 in Acute Myleoid Leukemia to Improve Autophagy-Dependent Differentiation Therapy
  Prof T Ochsenreiter, Prof MT Tschan
Application Deadline: 28 February 2019
The tumor protein, translationally-controlled 1 (TPT1) is a multifunctional, universally conserved protein implicated as a potential drug target in human cancer therapy.
  Migration of malignant B cells and their adaptive response to BCR inhibitor therapy
  Prof M Mráz
Application Deadline: 3 February 2019
We are looking for a motivated PhD student that would like to work on the following project funded by the ERC (European Research Council) Starting grant.
  Non-coding RNAs (microRNAS/lncRNAS) and microenvironmental interactions of malignant B-cells
  Prof M Mráz
Application Deadline: 15 March 2019
We are looking for a motivated PhD student that would like to work on the following project funded by the ERC (European Research Council) Starting grant.
  Regulation of BCR signalling by DNA damage response and P53 protein
  Prof M Mráz
Application Deadline: 15 March 2019
We are looking for a motivated PhD student that would like to work on the following project funded by the ERC (European Research Council) Starting grant.
  How is fate determined during T cell development, leukemogenesis and responses?
  Dr S. Russell
Applications accepted all year round
Understanding how cell fate programming works will lead to improved diagnostic and therapeutic opportunities for leukemia, and to improved immunotherapies for cancer and infectious disease.
  Elucidating the role of chromatin and epigenetic modifiers in Acute Myeloid Leukaemia.
  Research Group: Centre for Cancer Research and Cell Biology
  Prof K Mills, Dr AT Kruythoff-Mohd Sarip
Application Deadline: 20 January 2019
Progression and characteristics of Acute myeloid leukemia (AML) has been linked to several key pathways including inactivation of tumour suppressors and gain-of-function mutation of oncogenes.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round
Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  MRC DTP 4 Year PhD Programme: Dissecting the epigenetic regulation of enhancer function in hematopoiesis
  Dr K Rasmussen, Dr G Schweikert
Application Deadline: 18 January 2019
This project is part of our exciting and challenging University of Dundee 4-year MRC DTP Programme in Quantitative and Interdisciplinary approaches to biomedical science.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.